The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy

Sameer Islam, Ethan D. Miller, Neal Patel, Giovanni De Petris, W Edward Jr. Highsmith, David E. Fleischer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

GOALS: To underscore the utility of DNA fingerprinting for clarifying disparate results from endoscopic pathologic specimens. BACKGROUND: Occasionally, serially obtained gastrointestinal biopsies may yield inconsistent results. These discrepancies pose a dilemma for gastroenterologists and their patients, especially when malignancy is a consideration. STUDY: Patients referred to our tertiary care center from outside institutions had undergone endoscopically obtained esophageal biopsies showing malignancy, verified by pathologists at both our site and from the referring center. Repeat endoscopic biopsies at our center did not show malignancy. To verify that different sets of biopsies came from the same patient, we performed a polymerase chain reaction-based analysis comparing the 2 specimens. This analysis, called DNA fingerprinting, can show a high degree of certainty whether 2 specimens came from the same patient. RESULTS: In each case, DNA fingerprinting verified a match, laying the groundwork for intervention. One patient underwent endoscopic radiofrequency ablation to the esophageal mucosa involved. Another underwent esophagectomy with partial gastrectomy. Both are doing well clinically and remain cancer-free on follow-up. CONCLUSIONS: DNA fingerprinting is a powerful and a relatively inexpensive tool. Usually, only small amounts of tissue are required, and even degraded or archival tissue is adequate. DNA fingerprinting can be an important tool in the gastroenterologist's arsenal to help clarify conflicting results, allowing the patient and physician to move forward with the management.

Original languageEnglish (US)
Pages (from-to)239-241
Number of pages3
JournalJournal of Clinical Gastroenterology
Volume47
Issue number3
DOIs
StatePublished - Mar 2013

Fingerprint

DNA Fingerprinting
Biopsy
Neoplasms
Esophagectomy
Gastrectomy
Tertiary Care Centers
Physicians
Polymerase Chain Reaction

Keywords

  • Barrett esophagus
  • DNA fingerprinting
  • esophageal cancer
  • intestinal metaplasia
  • malignancy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy. / Islam, Sameer; Miller, Ethan D.; Patel, Neal; De Petris, Giovanni; Highsmith, W Edward Jr.; Fleischer, David E.

In: Journal of Clinical Gastroenterology, Vol. 47, No. 3, 03.2013, p. 239-241.

Research output: Contribution to journalArticle

Islam, Sameer ; Miller, Ethan D. ; Patel, Neal ; De Petris, Giovanni ; Highsmith, W Edward Jr. ; Fleischer, David E. / The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy. In: Journal of Clinical Gastroenterology. 2013 ; Vol. 47, No. 3. pp. 239-241.
@article{1edc00fc8d5e4d58842f4b3f4adca26b,
title = "The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy",
abstract = "GOALS: To underscore the utility of DNA fingerprinting for clarifying disparate results from endoscopic pathologic specimens. BACKGROUND: Occasionally, serially obtained gastrointestinal biopsies may yield inconsistent results. These discrepancies pose a dilemma for gastroenterologists and their patients, especially when malignancy is a consideration. STUDY: Patients referred to our tertiary care center from outside institutions had undergone endoscopically obtained esophageal biopsies showing malignancy, verified by pathologists at both our site and from the referring center. Repeat endoscopic biopsies at our center did not show malignancy. To verify that different sets of biopsies came from the same patient, we performed a polymerase chain reaction-based analysis comparing the 2 specimens. This analysis, called DNA fingerprinting, can show a high degree of certainty whether 2 specimens came from the same patient. RESULTS: In each case, DNA fingerprinting verified a match, laying the groundwork for intervention. One patient underwent endoscopic radiofrequency ablation to the esophageal mucosa involved. Another underwent esophagectomy with partial gastrectomy. Both are doing well clinically and remain cancer-free on follow-up. CONCLUSIONS: DNA fingerprinting is a powerful and a relatively inexpensive tool. Usually, only small amounts of tissue are required, and even degraded or archival tissue is adequate. DNA fingerprinting can be an important tool in the gastroenterologist's arsenal to help clarify conflicting results, allowing the patient and physician to move forward with the management.",
keywords = "Barrett esophagus, DNA fingerprinting, esophageal cancer, intestinal metaplasia, malignancy",
author = "Sameer Islam and Miller, {Ethan D.} and Neal Patel and {De Petris}, Giovanni and Highsmith, {W Edward Jr.} and Fleischer, {David E.}",
year = "2013",
month = "3",
doi = "10.1097/MCG.0b013e3182688a6e",
language = "English (US)",
volume = "47",
pages = "239--241",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy

AU - Islam, Sameer

AU - Miller, Ethan D.

AU - Patel, Neal

AU - De Petris, Giovanni

AU - Highsmith, W Edward Jr.

AU - Fleischer, David E.

PY - 2013/3

Y1 - 2013/3

N2 - GOALS: To underscore the utility of DNA fingerprinting for clarifying disparate results from endoscopic pathologic specimens. BACKGROUND: Occasionally, serially obtained gastrointestinal biopsies may yield inconsistent results. These discrepancies pose a dilemma for gastroenterologists and their patients, especially when malignancy is a consideration. STUDY: Patients referred to our tertiary care center from outside institutions had undergone endoscopically obtained esophageal biopsies showing malignancy, verified by pathologists at both our site and from the referring center. Repeat endoscopic biopsies at our center did not show malignancy. To verify that different sets of biopsies came from the same patient, we performed a polymerase chain reaction-based analysis comparing the 2 specimens. This analysis, called DNA fingerprinting, can show a high degree of certainty whether 2 specimens came from the same patient. RESULTS: In each case, DNA fingerprinting verified a match, laying the groundwork for intervention. One patient underwent endoscopic radiofrequency ablation to the esophageal mucosa involved. Another underwent esophagectomy with partial gastrectomy. Both are doing well clinically and remain cancer-free on follow-up. CONCLUSIONS: DNA fingerprinting is a powerful and a relatively inexpensive tool. Usually, only small amounts of tissue are required, and even degraded or archival tissue is adequate. DNA fingerprinting can be an important tool in the gastroenterologist's arsenal to help clarify conflicting results, allowing the patient and physician to move forward with the management.

AB - GOALS: To underscore the utility of DNA fingerprinting for clarifying disparate results from endoscopic pathologic specimens. BACKGROUND: Occasionally, serially obtained gastrointestinal biopsies may yield inconsistent results. These discrepancies pose a dilemma for gastroenterologists and their patients, especially when malignancy is a consideration. STUDY: Patients referred to our tertiary care center from outside institutions had undergone endoscopically obtained esophageal biopsies showing malignancy, verified by pathologists at both our site and from the referring center. Repeat endoscopic biopsies at our center did not show malignancy. To verify that different sets of biopsies came from the same patient, we performed a polymerase chain reaction-based analysis comparing the 2 specimens. This analysis, called DNA fingerprinting, can show a high degree of certainty whether 2 specimens came from the same patient. RESULTS: In each case, DNA fingerprinting verified a match, laying the groundwork for intervention. One patient underwent endoscopic radiofrequency ablation to the esophageal mucosa involved. Another underwent esophagectomy with partial gastrectomy. Both are doing well clinically and remain cancer-free on follow-up. CONCLUSIONS: DNA fingerprinting is a powerful and a relatively inexpensive tool. Usually, only small amounts of tissue are required, and even degraded or archival tissue is adequate. DNA fingerprinting can be an important tool in the gastroenterologist's arsenal to help clarify conflicting results, allowing the patient and physician to move forward with the management.

KW - Barrett esophagus

KW - DNA fingerprinting

KW - esophageal cancer

KW - intestinal metaplasia

KW - malignancy

UR - http://www.scopus.com/inward/record.url?scp=84873921730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873921730&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e3182688a6e

DO - 10.1097/MCG.0b013e3182688a6e

M3 - Article

C2 - 23391868

AN - SCOPUS:84873921730

VL - 47

SP - 239

EP - 241

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 3

ER -